INVESTORS & MEDIA
News Release
Regeneron Announces Investor Conference Presentations
RBC Capital Markets Global Healthcare Conference at9:00 a.m. ET onTuesday, May 14, 2024 Jefferies Global Healthcare Conference at8:30 a.m. ET onWednesday, June 5, 2024 - Goldman Sachs 45th Annual Global Healthcare Conference at
8:00 a.m. ET onTuesday, June 11, 2024
The sessions may be accessed from the "Investors & Media" page of
About
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
For more information, please visit www.Regeneron.com or follow
Contact Information:
Investor Relations
914.847.8790
ryan.crowe@regeneron.com
![](https://ml.globenewswire.com/media/NmVmYzBjYmEtM2ZhOS00ODU3LWIwN2UtODJkNTAyYmYzZTY1LTEwMTc4MjM=/tiny/Regeneron-Pharmaceuticals-Inc-.png)
Source: Regeneron Pharmaceuticals, Inc.